Recce Pharmaceuticals Ltd (RCE) – ASX Release

Recce to give Opening R&D Address at 2019 World Antibiotic Resistance Congress

Dr John Prendergast will showcase the potential of New Synthetic Antibiotics

SYDNEY, Australia, 1 August 2019: Recce Pharmaceuticals Ltd (ASX: RCE) (Company), the Company pioneering the development of a new class of synthetic antibiotics, today announced that it will be delivering an Opening R&D Address at the World Anti-Microbial Resistance (AMR) Congress in Washington D.C., 7-8 November 2019.

The two-day World AMR Congress is the largest commercially focused conference with AMR at its centre, engaging more than 600 attendees from over 40 countries. It attracts key stakeholders from the pharma and biotech industry who are involved in the development of antimicrobial drugs and diagnostics, including healthcare payers, regulators and partners.

André Singer, General Manager, World Anti-Microbial Resistance Congress says: “We are proud to provide this platform for promising antibiotic programs to be introduced to the AMR community, such as Recce Pharmaceuticals’ synthetic polymer program which has the potential of transforming the way superbugs are targeted, through a new class of broad-spectrum antibiotics.”

 

Recce Chairman Dr. John Prendergast will give the 20-minute Opening Address, during which he will highlight the urgent need for new antibiotics to address AMR. The presentation will also afford the opportunity to provide an overview and update of Recce’s antibiotics pipeline as well as answer “How synthetic antibiotic development can change the antibiotic treatment model”.

“While addressing the key hurdles in antibiotic R&D such as push and pull incentives needed to reignite the sector, it is crucial to showcase ground-breaking antibiotic programs targeting a critical unmet medical need despite the current challenges to bring these therapies to the market” says Singer.

 

The information contained has been prepared by third parties. No warranty of accuracy or reliability is given in relation to any advice or information contained in this document and no responsibility for any loss or damage whatsoever arising in any way for any representation, act or omission, whether express or implied (including responsibility to any persons by reason of negligence), is given by DJ Carmichael Pty Limited or any officer, agent or employee of DJ Carmichael Pty Limited.